Companies › Aldeyra Therapeutics

Aldeyra Therapeutics

Healthcare 📍 Burlington, United States 👥 1-10 employees 💰 $7.8M raised 📅 Founded 2004

Aldeyra Therapeutics, Inc. develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases, and slow the progression of chronic disease. The company’s products target immune-mediated, inflammatory, orphan, and other diseases. It develops NS2, a compound that binds and traps free aldehyd

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
1-10
Total Raised · Post-IPO
$7.8M
Founded
2004
Cloud
Unknown
Email
Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
WorkspaceMicrosoft 365
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / PlatformWordPress
Frontend Stack🔒 Subscribers only

Detected from Aldeyra Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction